ACE2 and COVID-19: Moreover, COVID-19 patients present hyperactivated ACE2-positive [20] and CD147-positive [21] platelets, which supports the notion of SARS-CoV-2 directly participating in the observed thrombus formation and inflammation in COVID-19 subjects.